(Q47234237)

12 January 2018

title

Statistical issues including design and sample size calculation in thorough QT/QTc studies (English)

1 reference

12 January 2018

0 references

Joanne Zhang

1

1 reference

12 January 2018

Stella G Machado

series ordinal

2

1 reference

12 January 2018

publication date

1 January 2008

1 reference

12 January 2018

Journal of Biopharmaceutical Statistics

published in

1 reference

12 January 2018

volume

18

1 reference

12 January 2018

issue

3

1 reference

12 January 2018

page(s)

451-467

1 reference

12 January 2018

New confidence bounds for QT studies

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Interim analyses for monitoring clinical trials that do not materially affect the type I error rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Planning and revising the sample size for a trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Sample sizes for clinical trials with normal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Re-calculating the sample size in internal pilot study designs with control of the type I error rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Effects of cisapride on QT interval in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Timing of new black box warnings and withdrawals for prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Multiple Hypothesis Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400802020938

10.1080/10543400802020938

21 January 2018

Identifiers

DOI

1 reference

12 January 2018

PubMed ID

18470755

1 reference

12 January 2018